Joshi, M., Pero, S. C., Durocher, Y., Sun, Y., Shukla, G., Murphy, C., Barrantes-Reynolds, R., Bernard, C., Welch, G., Krag, D. N. (2026). Phase 1, open-label clinical trial to treat stage IV cancer patients harboring multiple patient-specific mutated cell surface proteins with chimeric antibodies.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps2672